The lipase testing reagents market is projected to grow from USD 723.0 million in 2025 to USD 1,422.3 million by 2035, at a CAGR of 7.0%. Pancreatic Disorders will dominate with a 51.8% market share, while hospitals will lead the end-user segment with a 45.6% share.